Obesity (Silver Spring) · 2008
Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's diseaseConclusion: TE produced a placebo-subtracted weight loss of approximately 4% for >14 weeks without any diet and lifestyle therapy, which is similar to that of sibutramine, but with no effect on blood pressure. On the basis of these results, TE is now being developed for obesity management.